A new contrast media for functional MR urography: Gd-MAG3

Medical Hypotheses

Volumn 77, Issue 1, 2011, Pages 74-76

  Algin, Oktay ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

MERTIATIDE TC 99M; PENTETATE TECHNETIUM TC 99M;

ARTICLE; CHELATION; CONTRAST ENHANCEMENT; DRUG DISTRIBUTION; FEASIBILITY STUDY; FUNCTIONAL MAGNETIC RESONANCE UROGRAPHY; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY DYSFUNCTION; KIDNEY TRANSPLANTATION; NEPHROTOXICITY; RADIATION HAZARD; UROGENITAL SYSTEM EXAMINATION; UROGRAPHY;

ANTIGENS, DERMATOPHAGOIDES; ANTIGENS, PLANT; CONTRAST MEDIA; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; UROGRAPHY;

EID: 79958028538     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.03.029     Document Type: Article

References (19)

1. Jamar F., Barone R. Renal imaging. Nuclear medicine 2006, 83-100. Springer-Verlag, Berlin-Heidelberg. 2d ed.
2. Lonergan G.J., Pennington D.J., Morrison J.C., Haws R.M., Grimley M.S., Kao T.C. Childhood pyelonephritis: comparison of gadolinium-enhanced MR imaging and renal cortical scintigraphy for diagnosis. Radiology 1998, 207:377-384.
3. Algin O. Functional evaluation of kidneys: which technique is more useful?. AJR Am J Roentgenol 2010, 194(2):W241.
4. Vivier P.H., Blondiaux E., Dolores M., et al. Functional MR urography in children. J Radiol 2009, 90:11-19.
5. Vivier P.H., Dolores M., Taylor M., Elbaz F., Liard A., Dacher J.N. MR urography in children. Part 1: how we do the F0 technique. Pediatr Radiol 2010, 40:732-738.
6. Itoh K. 99mTc-MAG3: Review of pharmacokinetics, clinical application to renal diseases and quantification of renal function. Ann Nucl Med 2001, 15(3):179-190.
7. Aime S., Caravan P. Biodistribution of gadolinium-based contrast agents, including gadolinium deposition. J Magn Reson Imaging 2009, 30(6):1259-1267.
8. Vivier P.H., Dacher J.N. Contrast medium issues in MR urography. Acad Radiol 2009, 16:772.
9. Jones R.A., Schmotzer B., Little S.B., Grattaan-Smith J.D. MRU post-processing. Pediatr Radiol 2008, 38(suppl. 1):S18-S27.
10. Thomsen H.S. Guidelines for contrast media from the European society of urogenital radiology. AJR 2003, 181:1463-1471.
11. Muller-Suur R. Radiopharmaceuticals: their intrarenal handling and localization. Nuclear medicine in clinical diagnosis and treatment 1998, Vol. 2:211-228. Churchill Livingstone, Edinburgh.
12. Abram U., Alberto R. Technetium and Rhenium-coordination chemistry and nuclear medical applications. J Braz Chem Soc 2006, 17:1486-1500.
13. Bannister K.M., Penglis S., Bellen J.C., Baker R.J., Chatterton B.E. Kit preparation of technetium-99m-mercaptoacetyltriglycine: analysis, biodistribution and comparison with technetium-99m-DTPA in patients with impaired renal function. J Nucl Med 1990, 31:1568-1573.
14. Akin O., Agildere A.M. Contrast agents used in MRI. Diagn Interv Radiol 2000, 6:348-354.
15. Karabulut N., Elmas N. Contrast agents used in MR imaging of the liver. Diagn Interv Radiol 2006, 12:22-30.
16. Algin O., Ozlem N., Kilic E., Karaoglanoglu M., Arslan H. Gd-BOPTA enhanced MR cholangiography findings in gall bladder perforation. Emerg Radiol 2010, 17(6):487-491.
17. Rohrschneider W.K., Haufe S., Wiesel M., et al. Functional and morphologic evaluation of congenital urinary tract dilatation by using combined static-dynamic MR urography: findings in kidneys with a single collecting system. Radiology 2002, 224:683-694.
18. Boss A., Martirosian P., Gehrmann M., et al. Quantitative assessment of glomerular filtration rate with MR gadolinium slope clearance measurements: a phase I trial. Radiology 2007, 242:783-790.
19. Carr D.H., Brown J., Bydder G.M., et al. Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients. AJR 1984, 143:215-224.